Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Operating Expenses (2021 - 2025)

Historic Operating Expenses for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to $20.5 million.

  • Pulse Biosciences' Operating Expenses rose 4978.4% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.0 million, marking a year-over-year increase of 6285.73%. This contributed to the annual value of $56.3 million for FY2024, which is 2910.68% up from last year.
  • Latest data reveals that Pulse Biosciences reported Operating Expenses of $20.5 million as of Q3 2025, which was up 4978.4% from $20.3 million recorded in Q2 2025.
  • Pulse Biosciences' Operating Expenses' 5-year high stood at $20.5 million during Q3 2025, with a 5-year trough of $8.7 million in Q4 2022.
  • For the 5-year period, Pulse Biosciences' Operating Expenses averaged around $14.8 million, with its median value being $14.8 million (2021).
  • In the last 5 years, Pulse Biosciences' Operating Expenses plummeted by 4625.32% in 2022 and then surged by 7290.64% in 2025.
  • Pulse Biosciences' Operating Expenses (Quarter) stood at $16.3 million in 2021, then crashed by 46.25% to $8.7 million in 2022, then soared by 43.46% to $12.5 million in 2023, then skyrocketed by 61.66% to $20.3 million in 2024, then increased by 0.95% to $20.5 million in 2025.
  • Its Operating Expenses stands at $20.5 million for Q3 2025, versus $20.3 million for Q2 2025 and $18.0 million for Q1 2025.